Jazz Pharmaceuticals Plc · NASDAQ:JAZZ

Mulligan Seamus exercised options for 3,415 Jazz Pharmaceuticals Plc shares (Form 4)

Traded May 28, 2026 · Filed Jun 1, 2026

On May 28, 2026, Mulligan Seamus (Director) exercised options for 3,415 Jazz Pharmaceuticals Plc shares at US$138.08 for US$472K, leaving 1,183,028 shares. Filed Jun 1, 2026 (Form 4).

Options exercised
3,415 shares
Price
US$138.08
Value
US$472K
Holding after
1,183,028 shares
Trading plan
No
Role
Director

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 28, 2026Ordinary SharesOption exercise3,415US$138.081,183,028Direct

Source

View original at SEC

Related